Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

HCT survival in ADA-SCID: what's the buzz?

Chan SK, Shearer WT.

Blood. 2012 Oct 25;120(17):3392-3. doi: 10.1182/blood-2012-07-443960.

2.

Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.

Hassan A, Booth C, Brightwell A, Allwood Z, Veys P, Rao K, Hönig M, Friedrich W, Gennery A, Slatter M, Bredius R, Finocchi A, Cancrini C, Aiuti A, Porta F, Lanfranchi A, Ridella M, Steward C, Filipovich A, Marsh R, Bordon V, Al-Muhsen S, Al-Mousa H, Alsum Z, Al-Dhekri H, Al Ghonaium A, Speckmann C, Fischer A, Mahlaoui N, Nichols KE, Grunebaum E, Al Zahrani D, Roifman CM, Boelens J, Davies EG, Cavazzana-Calvo M, Notarangelo L, Gaspar HB; Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and European Society for Immunodeficiency..

Blood. 2012 Oct 25;120(17):3615-24; quiz 3626. doi: 10.1182/blood-2011-12-396879.

3.

A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.

Tartibi HM, Hershfield MS, Bahna SL.

Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-2169.

PMID:
26684479
4.
5.

Recombinant adeno-associated virus-mediated gene transfer for the potential therapy of adenosine deaminase-deficient severe combined immune deficiency.

Silver JN, Elder M, Conlon T, Cruz P, Wright AJ, Srivastava A, Flotte TR.

Hum Gene Ther. 2011 Aug;22(8):935-49. doi: 10.1089/hum.2010.121.

PMID:
21142972
6.

Gene therapy for ADA-SCID: defining the factors for successful outcome.

Gaspar HB.

Blood. 2012 Nov 1;120(18):3628-9. doi: 10.1182/blood-2012-08-446559. No abstract available.

7.

Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency.

Booth C, Algar VE, Xu-Bayford J, Fairbanks L, Owens C, Gaspar HB.

J Clin Immunol. 2012 Jun;32(3):449-53. doi: 10.1007/s10875-012-9658-3.

PMID:
22350222
8.

A tale of two SCIDs.

Shaw KL, Kohn DB.

Sci Transl Med. 2011 Aug 24;3(97):97ps36. doi: 10.1126/scitranslmed.3002594.

PMID:
21865536
9.

Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.

Gaspar HB, Bjorkegren E, Parsley K, Gilmour KC, King D, Sinclair J, Zhang F, Giannakopoulos A, Adams S, Fairbanks LD, Gaspar J, Henderson L, Xu-Bayford JH, Davies EG, Veys PA, Kinnon C, Thrasher AJ.

Mol Ther. 2006 Oct;14(4):505-13.

PMID:
16905365
10.

Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency.

Ferrua F, Brigida I, Aiuti A.

Curr Opin Allergy Clin Immunol. 2010 Dec;10(6):551-6. doi: 10.1097/ACI.0b013e32833fea85. Review.

PMID:
20966749
11.

Effects of enzyme replacement therapy on immune function in ADA deficiency patient.

Nakazawa Y, Kawai T, Uchiyama T, Goto F, Watanabe N, Maekawa T, Ishiguro A, Okuyama T, Otsu M, Yamada M, Hershfield MS, Ariga T, Onodera M.

Clin Immunol. 2015 Dec;161(2):391-3. doi: 10.1016/j.clim.2015.06.011. No abstract available.

PMID:
26122173
12.

Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome.

Nikolajeva O, Worth A, Hague R, Martinez-Alier N, Smart J, Adams S, Davies EG, Gaspar HB.

J Clin Immunol. 2015 May;35(4):366-72. doi: 10.1007/s10875-015-0158-0. Erratum in: J Clin Immunol. 2016 May;36(4):413.

PMID:
25875700
13.

Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion.

Carbonaro DA, Jin X, Cotoi D, Mi T, Yu XJ, Skelton DC, Dorey F, Kellems RE, Blackburn MR, Kohn DB.

Blood. 2008 Jun 15;111(12):5745-54. doi: 10.1182/blood-2007-08-103663.

14.

Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006).

Booth C, Hershfield M, Notarangelo L, Buckley R, Hoenig M, Mahlaoui N, Cavazzana-Calvo M, Aiuti A, Gaspar HB.

Clin Immunol. 2007 May;123(2):139-47. Review.

PMID:
17300989
15.

Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications.

Hönig M, Albert MH, Schulz A, Sparber-Sauer M, Schütz C, Belohradsky B, Güngör T, Rojewski MT, Bode H, Pannicke U, Lippold D, Schwarz K, Debatin KM, Hershfield MS, Friedrich W.

Blood. 2007 Apr 15;109(8):3595-602.

16.
17.

Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID).

Kühl JS, Schwarz K, Münch A, Schmugge M, Pekrun A, Meisel C, Wahn V, Ebell W, von Bernuth H.

Klin Padiatr. 2011 Mar;223(2):85-9. doi: 10.1055/s-0030-1269916.

PMID:
21271505
18.

Severe combined immunodeficiency due to adenosine deaminase deficiency.

Hussain W, Batool A, Ahmed TA, Bashir MM.

J Pak Med Assoc. 2012 Mar;62(3):297-9.

19.

Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.

Candotti F, Shaw KL, Muul L, Carbonaro D, Sokolic R, Choi C, Schurman SH, Garabedian E, Kesserwan C, Jagadeesh GJ, Fu PY, Gschweng E, Cooper A, Tisdale JF, Weinberg KI, Crooks GM, Kapoor N, Shah A, Abdel-Azim H, Yu XJ, Smogorzewska M, Wayne AS, Rosenblatt HM, Davis CM, Hanson C, Rishi RG, Wang X, Gjertson D, Yang OO, Balamurugan A, Bauer G, Ireland JA, Engel BC, Podsakoff GM, Hershfield MS, Blaese RM, Parkman R, Kohn DB.

Blood. 2012 Nov 1;120(18):3635-46. doi: 10.1182/blood-2012-02-400937.

20.

Bone marrow gene therapy for adenosine deaminase deficiency.

Kaptein LC, Einerhand MP, Braakman E, Valerio D, van Beusechem VW.

Immunodeficiency. 1993;4(1-4):335-45. Review.

PMID:
7909479
Items per page

Supplemental Content

Support Center